Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SOFOSBUVIR\VELPATASVIR vs SOLRIAMFETOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SOFOSBUVIR\VELPATASVIR vs SOLRIAMFETOL: Safety Overview

Metric SOFOSBUVIR\VELPATASVIR SOLRIAMFETOL
Total FAERS Reports 18,042 2,135
Deaths Reported 978 9
Death Rate 5.4% 0.4%
Hospitalizations 2,342 75
Average Patient Age 54.5 yrs 43.2 yrs
% Female Patients 42.5% 71.4%
FDA Approval Date N/A Jun 17, 2019
Manufacturer N/A Axsome Therapeutics, Inc.
Route N/A ORAL
Marketing Status N/A Prescription